# Unveiling Immune System Perturbations in Early Development Through Zebrafish Models of NADHX Repair Deficiency

**Authors:** Myrto Patraskaki, Najmesadat Seyedkatouli, Lisa Schlicker, Marc O. Warmoes, Maria Lorena Cordero‐Maldonado, Ursula Heins‐Marroquin, Carole L. Linster

PMC · DOI: 10.1002/jimd.70149 · Journal of Inherited Metabolic Disease · 2026-02-01

## TL;DR

Zebrafish models of NADHX repair deficiency reveal immune system issues and potential treatments for a rare neurological disease.

## Contribution

The study introduces zebrafish models of NADHX repair deficiency and identifies immune system involvement in PEBEL disease.

## Key findings

- NAXD-deficient zebrafish show severe symptoms and are partially rescued by nicotinic acid.
- Both NAXD and NAXE mutants display immune system dysregulation and increased microglial activity.
- The zebrafish models are useful for studying PEBEL disease mechanisms and drug screening.

## Abstract

The vital cofactors NADH and NADPH are prone to hydration, forming hydroxylated redox‐inactive derivatives (NADHX and NADPHX) in cells. These damaged metabolites are repaired by two highly conserved enzymes, an NAD(P)HX dehydratase (NAXD) and an NAD(P)HX epimerase (NAXE). Mutations in NAXE or NAXD cause early onset progressive encephalopathy (PEBEL1 or PEBEL2), typically induced by fever or other triggers, and leading to premature death. To advance our comprehension of the disease mechanism and investigate potential therapeutic strategies, we generated zebrafish lines deficient in naxe or naxd using CRISPR/Cas9 technology. While both models accumulated NADHX, only naxd

−/−
 larvae developed a severe phenotype, showing reduced locomotion and early death, which was partially rescued by nicotinic acid supplementation. Both mutant lines displayed signs of dysregulated immune function based on gene expression analyses and increased neutral red staining in the head region, indicating an increased number or activation of microglial cells. Our findings suggest that immune system perturbations play a role in PEBEL disease development, aligning with its inflammatory trigger‐induced nature in humans. The naxd
−/− model's responsiveness to nicotinic acid underscores its utility for preclinical drug screening. Overall, these models will be instrumental in furthering our understanding of PEBEL disease mechanisms and enhancing translational research efforts.

## Linked entities

- **Genes:** NAXE (NAD(P)HX epimerase) [NCBI Gene 128240], NAXD (NAD(P)HX dehydratase) [NCBI Gene 55739]
- **Chemicals:** NADH (PubChem CID 439153), NADPH (PubChem CID 5884), NADPHX (PubChem CID 146037229), nicotinic acid (PubChem CID 938)
- **Diseases:** PEBEL1 (MONDO:0020781), PEBEL2 (MONDO:0034121)
- **Species:** Danio rerio (taxon 7955)

## Full-text entities

- **Genes:** c7b (complement component 7b) [NCBI Gene 570832] {aka c7, cb349, si:dkey-246j23.5, wu:fa01f03}, rpl13 (ribosomal protein L13) [NCBI Gene 378961] {aka zgc:92272}, ifit15 (interferon-induced protein with tetratricopeptide repeats 15) [NCBI Gene 322336] {aka IFIT17B, ifit2, wu:fb58d07}, pcdh1g2 (protocadherin 1 gamma 2) [NCBI Gene 553986] {aka DrPcdh1ga2, pcdh1ga2}, ebi3 (Epstein-Barr virus induced 3) [NCBI Gene 100134974] {aka il-27rb, si:dkey-97a13.4}, irf1b (interferon regulatory factor 1b) [NCBI Gene 792160] {aka IRF1, irf11, sb:eu922, zgc:103566}, fbxo30a (F-box protein 30a) [NCBI Gene 100001417] {aka fbxo30, zgc:63656}, naxe (NAD(P)HX epimerase) [NCBI Gene 436891] {aka apoa1bp, zgc:92263}, irf7 (interferon regulatory factor 7) [NCBI Gene 393650] {aka wu:fl24c03, zgc:66043, zgc:77947}, tnfb (tumor necrosis factor b (TNF superfamily, member 2)) [NCBI Gene 554167] {aka Tnf-alpha, tnf, tnfa-like}, il1b (interleukin 1, beta) [NCBI Gene 405770] {aka il1-b, zgc:111873}, NAXE (NAD(P)HX epimerase) [NCBI Gene 128240] {aka AIBP, APOA1BP, PEBEL, YJEFN1}, P2RY12 (purinergic receptor P2Y12) [NCBI Gene 64805] {aka ADPG-R, BDPLT8, HORK3, P2T(AC), P2Y(12)R, P2Y(AC)}, mxb (myxovirus (influenza) resistance B) [NCBI Gene 360143], atf3 (activating transcription factor 3) [NCBI Gene 393939] {aka zgc:55526}, tnfa (tumor necrosis factor a (TNF superfamily, member 2)) [NCBI Gene 405785], NAXD (NAD(P)HX dehydratase) [NCBI Gene 55739] {aka CARKD, LP3298, PEBEL2}, NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8) [NCBI Gene 4714] {aka ASHI, CI-ASHI, MC1DN32}, pim3 (Pim-3 proto-oncogene, serine/threonine kinase) [NCBI Gene 565041] {aka zgc:113028}, rsad2 (radical S-adenosyl methionine domain containing 2) [NCBI Gene 570456] {aka SAND, si:ch211-276e8.2, vig1, zgc:112342}, p2ry12 (purinergic receptor P2Y12) [NCBI Gene 100149618], LOC101885672 (E3 ubiquitin-protein ligase NEURL3) [NCBI Gene 101885672] {aka neurl3}, naxd (NAD(P)HX dehydratase) [NCBI Gene 797867] {aka carkd, zgc:171429}, ptgr1.1 (prostaglandin reductase 1, tandem duplicate 1) [NCBI Gene 494108] {aka ltb4dh, ptgr1, wu:fj35e05, zgc:101689}, actb1 (actin, beta 1) [NCBI Gene 57934] {aka ACTB, B-ACTZF, actba, bact, bactin1, bactzf}, hspb9 (heat shock protein, alpha-crystallin-related, 9) [NCBI Gene 100137108], il10 (interleukin 10) [NCBI Gene 553957] {aka zgc:194510, zgc:194518}, adamts13 (ADAM metallopeptidase with thrombospondin type 1 motif, 13) [NCBI Gene 100320289], yjefn3 (YjeF N-terminal domain containing 3) [NCBI Gene 557840] {aka apoa1bp2, si:ch211-212d10.3}, tmprss6 (transmembrane serine protease 6) [NCBI Gene 100005420], ATP5MC1 (ATP synthase membrane subunit c locus 1) [NCBI Gene 516] {aka ATP5A, ATP5G, ATP5G1}, il6 (interleukin 6 (interferon, beta 2)) [NCBI Gene 100885851], mxc (myxovirus (influenza virus) resistance C) [NCBI Gene 360145] {aka zgc:91988}, ifnphi1 (interferon phi 1) [NCBI Gene 360134] {aka ifn, ifn1, ifnab}
- **Diseases:** morphological abnormalities (MESH:D000013), Encephalopathy (MESH:D001927), febrile illness (MESH:D005334), skin lesions (MESH:D012871), necrotic (MESH:D009336), hypothermia (MESH:D007035), inflammation (MESH:D007249), leukodystrophy (MESH:D007966), PEBEL (OMIM:617186), tumorigenesis (MESH:D063646), microglial dysfunction (MESH:D006331), thrombotic thrombocytopenic purpura (MESH:D011697), Naxd Deficiency (MESH:D007153), atherogenesis (MESH:D050197), neurological (MESH:D009461), hypotonia (MESH:D009123), viral infections (MESH:D014777), neurometabolic disorder (MESH:D009358), Leigh syndrome (MESH:D007888), Brain Edema (MESH:D001929), immune (MESH:D007154), death (MESH:D003643), cognitive impairment (MESH:D003072), respiratory failure (MESH:D012131), Leukoencephalopathy (MESH:D056784), seizures (MESH:D012640), dysmorphia (MESH:C537340), toxicity (MESH:D064420), microcytic anemia (MESH:C536357), mitochondrial disease (MESH:D028361), neurodevelopmental defects (MESH:D065886), neurodegeneration (MESH:D019636), neural tube defects (MESH:D009436), NAXD deficiency (MESH:C562618), locomotor decline (MESH:D001523), immune dysregulation (OMIM:614878), juvenile amyotrophic lateral sclerosis and neuropathy (MESH:C565957), muscle dystrophies (MESH:D009136), sarcopenia (MESH:D055948)
- **Chemicals:** NAD (MESH:D009243), cholesterol (MESH:D002784), LPS (MESH:D008070), water (MESH:D014867), NAD(P) (MESH:D009249), NADHX (MESH:C058017), K+ (MESH:D011188), serine (MESH:D012694), reactive oxygen species (MESH:D017382), R- (MESH:D001120), NA (MESH:D009525), ATP (MESH:D000255), DreamTaq (-), galactose (MESH:D005690), B3 (MESH:C053396), lipid (MESH:D008055), TRIzol (MESH:C411644), prostaglandins (MESH:D011453), nicotinamide (MESH:D009536), Neutral Red (MESH:D009499), Agarose (MESH:D012685)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Artemia salina (species) [taxon 85549], Danio rerio (leopard danio, species) [taxon 7955]
- **Mutations:** c.757delG, serine/threonine, p.Y78*
- **Cell lines:** HAP1 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_Y019), -28a — Oryctolagus cuniculus (Rabbit), Transformed cell line (CVCL_6E94)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12861718/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12861718/full.md

## References

88 references — full list in the complete paper: https://tomesphere.com/paper/PMC12861718/full.md

---
Source: https://tomesphere.com/paper/PMC12861718